Amber N.A.N.EdinoffAmber N.A.N. i inni, Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review, „Pain and Therapy”, 12 (5), 2023, s. 1121–1134, DOI: 10.1007/s40122-023-00539-5, PMID: 37453966, PMCID: PMC10444703 [dostęp 2024-02-08](ang.).
Benjamin AdamB.A.SamuelsBenjamin AdamB.A. i inni, The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor, „Neuropsychopharmacology”, 42 (10), 2017, s. 2052–2063, DOI: 10.1038/npp.2017.60, PMID: 28303899, PMCID: PMC5561344 [dostęp 2024-02-08](ang.).
Kirsten E.K.E.SmithKirsten E.K.E. i inni, When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use, „The American Journal of Drug and Alcohol Abuse”, 47 (4), 2021, s. 455–466, DOI: 10.1080/00952990.2021.1904408, PMID: 33909525, PMCID: PMC8380661 [dostęp 2024-02-08](ang.).
PiotrP.WlaźPiotrP. i inni, NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice, „Pharmacological reports: PR”, 63 (6), 2011, s. 1526–1532, DOI: 10.1016/s1734-1140(11)70716-2, ISSN1734-1140, PMID: 22358100 [dostęp 2022-03-11](ang.).
Bruce S.B.S.McEwenBruce S.B.S. i inni, The neurobiological properties of Tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation, „Molecular psychiatry”, 15 (3), 2010, s. 237–249, DOI: 10.1038/mp.2009.80, ISSN1359-4184, PMID: 19704408, PMCID: PMC2902200 [dostęp 2022-03-11](ang.).
KoenK.SchruersKoenK., EricE.GriezEricE., The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder, „Journal of Psychopharmacology”, 18 (4), 2004, s. 553–558, DOI: 10.1177/0269881104047283, PMID: 15582922 [dostęp 2022-11-13](ang.).
KhK.ReetaKhK., PankajP.PrabhakarPankajP., Yogendra K.Y.K.GuptaYogendra K.Y.K., Anticonvulsant activity of the antidepressant drug, tianeptine, against pentylenetetrazole-induced seizures mitigates cognitive impairment in rats, „Behavioural Pharmacology”, 27 (7), 2016, s. 623–632, DOI: 10.1097/FBP.0000000000000257, PMID: 27561095 [dostęp 2022-11-13](ang.).
F.F.LechinF.F., B. van derB.DijsB. van derB., A.E.A.E.LechinA.E.A.E., Treatment of bronchial asthma with tianeptine, „Methods and Findings in Experimental and Clinical Pharmacology”, 26 (9), 2004, s. 697–701, DOI: 10.1358/mf.2004.26.9.872567, PMID: 15632955(ang.).
HelmutH.NiederhoferHelmutH., Tianeptine as a slightly effective therapeutic option for attention-deficit hyperactivity disorder, „Neuropsychobiology”, 49 (3), 2004, s. 130–133, DOI: 10.1159/000076721, PMID: 15034228(ang.).
nih.gov
ncbi.nlm.nih.gov
Amber N.A.N.EdinoffAmber N.A.N. i inni, Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review, „Pain and Therapy”, 12 (5), 2023, s. 1121–1134, DOI: 10.1007/s40122-023-00539-5, PMID: 37453966, PMCID: PMC10444703 [dostęp 2024-02-08](ang.).
Benjamin AdamB.A.SamuelsBenjamin AdamB.A. i inni, The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor, „Neuropsychopharmacology”, 42 (10), 2017, s. 2052–2063, DOI: 10.1038/npp.2017.60, PMID: 28303899, PMCID: PMC5561344 [dostęp 2024-02-08](ang.).
Kirsten E.K.E.SmithKirsten E.K.E. i inni, When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use, „The American Journal of Drug and Alcohol Abuse”, 47 (4), 2021, s. 455–466, DOI: 10.1080/00952990.2021.1904408, PMID: 33909525, PMCID: PMC8380661 [dostęp 2024-02-08](ang.).
PiotrP.WlaźPiotrP. i inni, NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice, „Pharmacological reports: PR”, 63 (6), 2011, s. 1526–1532, DOI: 10.1016/s1734-1140(11)70716-2, ISSN1734-1140, PMID: 22358100 [dostęp 2022-03-11](ang.).
Bruce S.B.S.McEwenBruce S.B.S. i inni, The neurobiological properties of Tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation, „Molecular psychiatry”, 15 (3), 2010, s. 237–249, DOI: 10.1038/mp.2009.80, ISSN1359-4184, PMID: 19704408, PMCID: PMC2902200 [dostęp 2022-03-11](ang.).
KoenK.SchruersKoenK., EricE.GriezEricE., The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder, „Journal of Psychopharmacology”, 18 (4), 2004, s. 553–558, DOI: 10.1177/0269881104047283, PMID: 15582922 [dostęp 2022-11-13](ang.).
KhK.ReetaKhK., PankajP.PrabhakarPankajP., Yogendra K.Y.K.GuptaYogendra K.Y.K., Anticonvulsant activity of the antidepressant drug, tianeptine, against pentylenetetrazole-induced seizures mitigates cognitive impairment in rats, „Behavioural Pharmacology”, 27 (7), 2016, s. 623–632, DOI: 10.1097/FBP.0000000000000257, PMID: 27561095 [dostęp 2022-11-13](ang.).
F.F.LechinF.F., B. van derB.DijsB. van derB., A.E.A.E.LechinA.E.A.E., Treatment of bronchial asthma with tianeptine, „Methods and Findings in Experimental and Clinical Pharmacology”, 26 (9), 2004, s. 697–701, DOI: 10.1358/mf.2004.26.9.872567, PMID: 15632955(ang.).
HelmutH.NiederhoferHelmutH., Tianeptine as a slightly effective therapeutic option for attention-deficit hyperactivity disorder, „Neuropsychobiology”, 49 (3), 2004, s. 130–133, DOI: 10.1159/000076721, PMID: 15034228(ang.).
PiotrP.WlaźPiotrP. i inni, NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice, „Pharmacological reports: PR”, 63 (6), 2011, s. 1526–1532, DOI: 10.1016/s1734-1140(11)70716-2, ISSN1734-1140, PMID: 22358100 [dostęp 2022-03-11](ang.).
Bruce S.B.S.McEwenBruce S.B.S. i inni, The neurobiological properties of Tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation, „Molecular psychiatry”, 15 (3), 2010, s. 237–249, DOI: 10.1038/mp.2009.80, ISSN1359-4184, PMID: 19704408, PMCID: PMC2902200 [dostęp 2022-03-11](ang.).